William Garrett Nichols serves as Executive at Candel Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, William Garrett Nichols has executed 9 insider transactions totaling $139.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 28, 2025 involved selling 937 shares valued at $6.5K.
William Garrett Nichols currently holds 52,493 shares of Candel Therapeutics, Inc. (CADL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, William Garrett Nichols has been a net seller of CADL stock. They have purchased $0 and sold $139.2K worth of shares.
William Garrett Nichols's most recent insider trade was on Jul 28, 2025, when they sold 937 shares at $6.98 per share.
Get notified when new Form 4 filings are submitted
| $1.29 |
| Discretionary |
| Jun 30, 2025 | CADL | $3.9K | Sale | 781 | $5.04 | Discretionary |
| Jun 30, 2025 | CADL | $1.0K | Option Exercise | 781 | $1.29 | Discretionary |
| Jul 17, 2024 | CADL | $70.4K | Sale | 10,875 | $6.47 | Discretionary |
| Jul 11, 2024 | CADL | $58.3K | Sale | 9,769 | $5.97 | Discretionary |
| Nov 28, 2023 | CADL | $11.0K | Payment | 12,175 | $0.90 | Discretionary |
| Nov 26, 2023 | CADL | $0 | Award | 88,822 | $N/A | Discretionary |
| Nov 28, 2022 | CADL | $0 | Award | 58,479 | $N/A | Discretionary |